WordNet

an acute and serious infection of the central nervous system caused by bacterial infection of open wounds; spasms of the jaw and laryngeal muscles may occur during the late stages (同)lockjaw
a sustained muscular contraction resulting from a rapid series of nerve impulses
immunogen consisting of a suspension of weakened or dead pathogenic cells injected in order to stimulate the production of antibodies (同)vaccinum
acute contagious infection caused by the bacterium Corynebacterium diphtheriae; marked by the formation of a false membrane in the throat and other air passages causing difficulty in breathing

PrepTutorEJDIC

《語・句・節を対等に結んで》…『と』…,…や…,および / 《数詞を結合して》…『足す』…,…に加えて / …『しかも』…,…して,同時に… / 《時間的に》『そして』,それから,すると(and then) / 《当然の帰結として》…『ので』,…だから(and so) / 《おもに話》《命令文などの後で》『そうすれば』,そうしたら / 《追加・強調して》それに,しかも / 《対照的な内容を導いて》ところが,しかし(but) / 《譲歩的に》それなのに,それでいながら / 《A and Bで一体の関係を表して》《単数扱い》 / 《同一語を反復して多数・継続などを表して》 / 《同一の複数名詞を結合して変化・種類などを表して》 / 《話》《「形容詞+and+形容詞」の形で前の形容詞が後に副詞的に働く》 / 《話》《「動詞come, goなど+and+動詞」の形でandとその後の動詞が不定詞の働きをして》 / 《「動詞+and+動詞」の形で後の動詞が現在分詞の意を表して》 / 《話》《文頭において前の質問・意見などに同意を示して》そうとも,そして(Yes!and) / 《話》《文頭に置いて驚き・疑念・非難などを表して》ほんとうに;…なのに
破傷風
牛痘種,痘苗(牛痘を起こすビールスで,天然痘予防のために人体に接種される) / (伝染病の病原菌から作った)ワクチン
ジフテリア(呼吸困難を起こすのどの病気)
(次にくる語の発音が母音で始まるときに用いる) / (子音[h]で始まり第1音節に強勢のない語の場合はanを用いることがある.ただし,この場合は[h]を発音しない)

UpToDate Contents

全文を閲覧するには購読必要です。 To read the full text you will need to subscribe.

1. 0～6歳の乳児および小児におけるジフテリア、破傷風、および百日咳ワクチン diphtheria tetanus and pertussis immunization in infants and children 0 through 6 years of age
2. 7～18歳の小児におけるジフテリア、破傷風、および百日咳ワクチン diphtheria tetanus and pertussis immunization in children 7 through 18 years of age
3. 思春期および成人における百日咳菌感染症の治療および予防 treatment and prevention of bordetella pertussis infection in adolescents and adults
4. 幼児および小児における百日咳菌感染症：治療および予防 bordetella pertussis infection in infants and children treatment and prevention
5. 成人における破傷風-ジフテリアトキソイドワクチン tetanus diphtheria toxoid vaccination in adults

English Journal

Distribution of aluminum in hair of Brazilian infants and correlation to aluminum-adjuvanted vaccine exposure.

Bohrer D1, Schmidt M2, Marques RC3, Dórea JG4.Author information 1Departamento de Química Analítica, Universidade Federal de Santa Maria, RS, Brazil.2Departamento de Química Analítica, Universidade Federal de Santa Maria, RS, Brazil. Electronic address: marcellaeps@gmail.com.3Universidade Federal do Rio de Janeiro, Campus Macaé, CEP 27930-560, RJ, Brazil. Electronic address: rejanecmarques@globo.com.4Departamento de Nutrição, Faculdade de Ciências da Saúde, Universidade de Brasília, Brasília, Brazil. Electronic address: jg.dorea@gmail.com.AbstractBACKGROUND: Nursing children are exposed to dietary aluminum (in breast milk and/or infant formulas) and through aluminum-adjuvanted vaccines (AAVs). We studied total hair-Al concentrations of nursing children that had been immunized with hepatitis B, DTP, and meningococcal vaccines.
Clinica chimica acta; international journal of clinical chemistry.Clin Chim Acta.2014 Jan 20;428:9-13. doi: 10.1016/j.cca.2013.10.020. Epub 2013 Oct 29.
BACKGROUND: Nursing children are exposed to dietary aluminum (in breast milk and/or infant formulas) and through aluminum-adjuvanted vaccines (AAVs). We studied total hair-Al concentrations of nursing children that had been immunized with hepatitis B, DTP, and meningococcal vaccines.METHODS: We stud
PMID 24183841

Safety and Immunogenicity of a Toddler Dose Following an Infant Series of a Hexavalent Diphtheria, Tetanus, Acellular Pertussis, Inactivated Poliovirus, Haemophilus influenzae Type b, Hepatitis B Vaccine Administered Concurrently or at Separate Visits With a Heptavalent Pneumococcal Conjugate Vaccine.

Halperin SA, Tapiéro B, Dionne M, Meekison W, Diaz-Mitoma F, Zickler P, Rubin E, Embree J, Bhuyan P, Lee A, Li M, Tomovici A.Author information From the *Canadian Center for Vaccinology, IWK Health Centre and Dalhousie University, Halifax, NS; †CHU Sainte Justine, University of Montreal, Montreal, QC; ‡CHUQ, Beauport, QC; §Westcoast Clinical Research, Coquitlam, BC; ¶Children's Hospital of Eastern Ontario, Ottawa, ON; ‖TASC Research, Surrey, BC; **Montreal Children's Hospital, Montreal, QC; ††University of Manitoba, Winnipeg, MB, Canada; ‡‡Merck Research Labs, Upper Gwynedd, PA; and §§Sanofi Pasteur Limited, Toronto, ON, Canada.AbstractBACKGROUND: Combination diphtheria-tetanus-5 component acellular pertussis-inactivated poliovirus-Haemophilus influenzae b conjugate-hepatitis B vaccine (DTaP5-IPV-Hib-HepB) administered either concurrently with 7-valent pneumococcal conjugate vaccine (PCV7) or 1 month apart was generally safe and immunogenic at 2, 4 and 6 months of age. This study examined the effects of a booster dose at age 15 months.
The Pediatric infectious disease journal.Pediatr Infect Dis J.2014 Jan;33(1):73-80. doi: 10.1097/01.inf.0000437806.76221.20.
BACKGROUND: Combination diphtheria-tetanus-5 component acellular pertussis-inactivated poliovirus-Haemophilus influenzae b conjugate-hepatitis B vaccine (DTaP5-IPV-Hib-HepB) administered either concurrently with 7-valent pneumococcal conjugate vaccine (PCV7) or 1 month apart was generally safe and i
PMID 24346596

Systematic review of the effect of pneumococcal conjugate vaccine dosing schedules on immunogenicity.

Deloria Knoll M, Park DE, Johnson TS, Chandir S, Nonyane BA, Conklin L, Fleming-Dutra KE, Loo JD, Goldblatt D, Whitney CG, O'Brien KL.Author information From the *International Vaccine Access Center, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD; †Biostatistics Consulting, Chicago, IL; ‡Respiratory Diseases Branch, Division of Bacterial Diseases, National Center for Immunizations and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA; §Epidemic Intelligence Service, Centers for Disease Control and Prevention, Atlanta, GA; ¶Institute of Child Health, University College London, London, United Kingdom.AbstractBACKGROUND: Despite the breadth of studies demonstrating benefits of pneumococcal conjugate vaccine (PCV), uncertainty remains regarding the optimal PCV dosing schedule in infants.
The Pediatric infectious disease journal.Pediatr Infect Dis J.2014 Jan;33 Suppl 2:S119-29. doi: 10.1097/INF.0000000000000079.
BACKGROUND: Despite the breadth of studies demonstrating benefits of pneumococcal conjugate vaccine (PCV), uncertainty remains regarding the optimal PCV dosing schedule in infants.METHODS: We conducted a systematic literature review of PCV immunogenicity published from 1994 to 2010 (supplemented pos
PMID 24336054

Japanese Journal

Correlation Between Pediatrician Supply and Public Health in Japan as Evidenced by Vaccination Coverage in 2010: Secondary Data Analysis

, , ,
Journal of Epidemiology advpub(0), 2015
… Since the scope of child vaccination is an indicator of preventive health service utilization, this study investigates the correlation between vaccination coverage and pediatrician supply as a reflection of overall pediatric health during a time of increasing pediatrician numbers in Japan.<BR>Methods: Cross-sectional data were collected from publicly available sources for 2010. …
NAID 130005062002

Immunization in Childhood in Japan: the Past, the Present, and the Future

順天堂醫事雑誌 60(5), 467-467, 2014
… DPT vaccine (diphtheria, tetanus, and pertussis) and Japanese encephalitis vaccine were introduced abroad from Japan. … In addition, the Japanese Oka strain used for varicella vaccine is the only strain recommended by the World Health Organization (WHO). …
NAID 130005064583

小児期の予防接種:過去，現在，そして未来

久田研
順天堂醫事雑誌 60(Suppl.2), s35-s41, 2014
HibやPCVの導入にはじまり，わが国の小児における予防接種政策は，停滞期を乗り越えワクチンギャップが解消されつつあります．予防接種法も一部改定され，基本方針に "予防接種で防げる疾病は予防する" という文言が掲げられました．HibやPCVの導入は，海外と同様に侵襲性感染症を減少させました．水痘ワクチンも定期接種化が予定され，その減少が期待されます．しかしながら，昨年度流行した風疹のように，過去の …
NAID 130005005481